Generic Name:Rituximab Indications Non-Hodgkin’s Lymphoma (NHL): Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent. Previously untreated follicular, CD20-positive, B-cell NHL in combination with first line chemotherapy and, in patients achieving a complete or partial response to a Rituxim product in combination with chemotherapy, as single-agent maintenance therapy. Non-progressing (including stable […]
Generic Name:Rosuvastatin Indications Resva is indicated in- Pharmacology Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methyl glutaryl coenzyme A to mevalonate, a precursor of cholesterol. Rosuvastatin produces its lipid-modifying effects in two ways. First, it increases the number of hepatic LDL receptors on the cell surface to […]
Generic Name:Pembrolizumab Indications Pemro is a programmed death receptor-1 (PD-1)-blocking antibody indicated: Melanoma: Non-Small Cell Lung Cancer (NSCLC): Small Cell Lung Cancer (SCLC): for the treatment of patients with metastatic SCLC with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy. Head and Neck Squamous Cell Cancer (HNSCC): […]
Generic Name:Pemetrexed Indications Pemetrex is indicated in Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Limitations of Use: Pemetrex is not indicated for the treatment of patients with squamous cell, non-small cell lung cancer. Mesothelioma: Pemetrex is indicated, in combination with Cisplatin, for the initial treatment of patients with malignant pleural mesothelioma whose disease is unresectable or […]
Generic Name:Palonosetron Hydrochloride Indications Paloxi indicated in- Pharmacology Palonosetron is a 5-HT3 receptor antagonist with a strong binding affinity for this receptor and little or no affinity for other receptors. It is thought that chemotherapeutic agents produce nausea and vomiting by releasing serotonin from the enterochromaffin cells of the small intestine and that the released […]
Generic Name:Calcium & Vitamin Indications Calcium and Vitamin D3 is used for the treatment of: To ensure adequate Calcium and Vitamin D3, it may also be used in certain conditions such as: Composition 500 mg & 200 IU: Each film-coated tablet contains Calcium Carbonate BP (eggshell source) 1250 mg equivalent to 500 mg of elemental […]
Generic Name:Nivolumab Indications Nivomab is a programmed death receptor-1 (PD-1)-blocking antibody indicated for the treatment of: Melanoma: Non-Small Cell Lung Cancer (NSCLC): Malignant Pleural Mesothelioma: adult patients with unresectable malignant pleural mesothelioma, as first-line treatment in combination with ipilimumab. Renal Cell Carcinoma (RCC): Classical Hodgkin Lymphoma (cHL): adult patients with classical Hodgkin lymphoma that has […]
Generic Name :Nanoparticle Albumin Bound Paclitaxel Indications Metastatic Breast Cancer: Nab-Xelpac is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated. Non-Small Cell Lung Cancer: Nab-Xelpac is indicated for the first-line treatment of locally […]
Generic Name:Megestrol Acetate Indications Mezest tablet is indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (i.e., recurrent, inoperable or metastatic disease). It should not be used instead of currently accepted procedures such as surgery, radiation or chemotherapy. Mezest oral suspension is indicated for the treatment of anorexia, cachexia, or an […]
Generic Name:Lenvatinib Mesylate Indications Lenva is a kinase inhibitor that is indicated: Pharmacology Lenvatinib is a kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib inhibits other kinases that have been implicated in pathogenic angiogenesis, tumor growth, and cancer progression in addition […]